SCHEMBL2202880

SCHEMBL2202880

COC(=O)Nc1ccc(C[C@](C)(NC(=O)c2ccc3c(C4CCCCC4)c4n(c3c2)CCOc2cc(OC)ccc2-4)C(=O)O)cc1

nearest known ligand 0.41

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 8/20 0.41
CYP2C19 P33261 6/20 0.41
NR1I2 O75469 5/20 0.41
CYP2C9 P11712 3/20 0.41
KCNH2 Q12809 7/20 0.39
CYP2D6 P10635 2/20 0.39
SCN5A Q14524 2/20 0.39
PRKCA P17252 1/20 0.38
MMP12 P39900 1/20 0.38
SCN9A Q15858 1/20 0.37
MAPT P10636 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL771847 0.95 CYP3A4 (0.40) CYP3A4CYP2C19NR1I2CYP2C9KCNH2
SCHEMBL772943 0.93 CYP3A4 (0.41) CYP3A4CYP2C19NR1I2CYP2C9KCNH2
SCHEMBL774125 0.93 CYP3A4 (0.41) CYP3A4CYP2C19NR1I2CYP2C9KCNH2
SCHEMBL772488 0.92 NR1I2 (0.40) CYP3A4CYP2C19NR1I2CYP2C9KCNH2
SCHEMBL771380 0.92 NR1I2 (0.40) CYP3A4CYP2C19NR1I2CYP2C9KCNH2
SCHEMBL771659 0.91 NR1I2 (0.39) CYP3A4CYP2C19NR1I2CYP2C9KCNH2
SCHEMBL773344 0.91 NR1I2 (0.40) CYP3A4CYP2C19NR1I2CYP2C9KCNH2
SCHEMBL775190 0.90 ESR1 (0.40) CYP3A4CYP2C19NR1I2CYP2C9KCNH2
SCHEMBL2202854 0.90 NR1I2 (0.39) CYP3A4CYP2C19NR1I2CYP2C9KCNH2
SCHEMBL772418 0.90 NR1I2 (0.38) CYP3A4CYP2C19NR1I2CYP2C9KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7977331-B1 Tetracyclic fused heterocyclic compound and use thereof as HCV polymerase inhibitor JAPAN TOBACCO INC. (JP) 2011-07-12 US disclosed